Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

National Glaucoma Research
Completed Award

Dr. Joel Schuman

Joel Schuman, M.D.

University of Pittsburgh
Pittsburgh, PA

Title: Spectral Domain OCT Doppler Assesses Aqueous Outflow
Non-Technical Title: A New Non-Contact Measurement of the Process that Controls Eye Pressure

Co-PI(s):
Larry Kagemann, M.S., Gadi Wollstein, M.D., Hiroshi Ishikawa, M.D.
University of Pittsburgh
Haiyan Gong, M.D., Ph.D.
Boston University

Acknowledgements: Recipient of the Thomas R. Lee award for National Glaucoma Research
Duration: April 1, 2010 - September 30, 2012
Award Type: Standard
Award Amount: $100,000

Summary:

The most important factor to consider in glaucoma is the pressure of the eye, which is controlled by the slow outflow of fluid within a drainage system in the front of the eye. We have developed a way to visualize and measure how fast this drainage occurs without touching the eye, and without any bright lights. This project is vital in two ways: 1- in order to validate the new measurement in a controlled environment designed to be nearly identical to that of the clinic, and 2- in order to finally visualize, for the first time, the entire system as it functions.

Details:

When this study is complete, glaucoma doctors will be able, for the first time, to actually measure how an eye responds to a glaucoma medication. Glaucoma surgeons will be able, for the first time, to actually know before the operation, where the best place to implant a drainage device would be. The field of glaucoma medicine will know, for the first time, how much of the drainage system is actually used under normal conditions. This may allow glaucoma doctors to detect the conditions that could lead up to pressure elevation and eye damage long before they actually occur.

This study will use eyes generously donated for medical research. The first aim of the study involves setting up drainage in an eye at a known rate, and measuring the size of and location of all key components of the drainage system. This will be the first time that anyone has documented the entire functioning drainage system as it operates. Data from this experiment will give us the best clue as to where it is important to make similar measurements in our patients.

One of our collaborators has studied the drainage system and has found that eye pressure might squeeze some components of the drainage system shut, but was only able to observe it in slices on a microscope. The second component of the experiment will change eye pressure and observe first-hand the effect of pressure on the size of those components. We will examine whether the components are able to rebound back to their original shape after an attack of high pressure, or if damage is permanent. This information could fundamentally change how glaucoma doctors respond to various levels of pressure in their patients, and help to prioritize their responses.

The final aim of the study involves combining measurements of fluid speed and "tube" size to calculate total observable flow. If the flow that we measure leaving through the drainage system matches the flow that we observe going into the eye, we will have validated the first non-contact technique capable of providing doctors immediate data on eye pressure regulation.

No one else is currently capable of making these measurements, and the information provided is at the very core of the processes that result in eye damage in glaucoma. We are incredibly excited to be part of their development, and cannot sufficiently express our gratitude to those willing to support this work.